The global herbal supplements market size is expected to reach US$ 191.7 Bn by the end of 2030.
The industry players are promoting these benefits widely, which in turn boosts the sales of herbal supplements worldwide.
The report provides a detailed analysis of the industry, covering key drivers of growth, restraints, opportunities and dominant patterns.
Through the course of the report’s forecast period, the market is exhibited to show a steady pace of growth.High demand for plant-based products and easy availability of herbs are driving regional market growth in countries like China and India.Rising geriatric population and the prevalence of chronic disorders in the area are expected to further fuel the Asia-Pacific demand for herbal supplements over the forecast period.The European market is projected to show the highest growth rate in the forecast period due to the increasing vegan population, followed by government policies to promote the consumption of organic goods, in particular in Germany and France.In the forecast period Asia-Pacific is expected to rise at the fastest CAGR.COVID-19 Outbreak will Impact Growth in the IndustryMany medicine manufacturing companies are launching herbal medicine products as these drugs are less susceptible to side effects, hence these factors function during the forecast period as a beneficial opportunity for the herbal supplements industry.
Herbal supplements are less successful and thus result in delayed recovery in many medical conditions hampering the growth of the market.Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11311Coronavirus outbreak had a major impact on buyers' consumption habits.
At this crucial juncture, all industry players are rooting unanimously for the government to support them.Who is winning?The key players in the global herbal supplements and remedies market include Sundown Nutrition, Twinlab Corporation, Martek Biosciences Corporation, Natures Aid, DSM Nutritional Products Ltd., i-Health, Inc., Nutraceutical Corporation, Ricola AG, Bio-Botanica, Inc., ARKOPHARMA Pharmaceutical Laboratories, and The Himalaya Drug Company.